Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,15668,633,1.32 [1.12-1.56],0.0010943625059262
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23374,85,1.62 [1.22-2.14],0.0007260616904014
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23371,82,1.65 [1.25-2.17],0.0003914112450558
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,21012,869,1.19 [1.02-1.37],0.0231017006190556
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),20825,337,1.27 [1.02-1.59],0.0306251041400568
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23228,87,1.45 [1.05-2.01],0.0247215248251859
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,19522,754,1.20 [1.02-1.42],0.0303852278562571
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,21562,750,1.38 [1.20-1.58],3.785202623039652e-06
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,21942,83,1.45 [1.01-2.10],0.0464853806404246
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18826,58,1.62 [1.14-2.30],0.0070756748912949
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Neurological diseases,20368,1389,1.14 [1.01-1.30],0.032784561960103
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22410,366,1.27 [1.04-1.57],0.0220664434004617
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23411,108,1.44 [1.06-1.95],0.0211338231673965
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,17292,2355,1.19 [1.07-1.34],0.0017426505368807
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Hypertension, essential",18197,1722,1.20 [1.06-1.36],0.0032751900289541
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypertension,18213,1738,1.20 [1.07-1.36],0.0028951800125508
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",21563,78,1.62 [1.15-2.29],0.0055086814761413
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Cardiomyopathy,20465,31,1.83 [1.20-2.78],0.0048087318663906
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22961,71,0.35 [0.13-0.93],0.0352595074068239
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,19127,1811,1.21 [1.09-1.35],0.0003836618042888
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23334,113,1.43 [1.07-1.92],0.0170005829917795
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22143,174,1.35 [1.03-1.77],0.0299816098252006
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22128,159,1.36 [1.03-1.80],0.0324696568067843
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,20970,998,1.17 [1.01-1.35],0.0309456181092929
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23246,79,1.73 [1.31-2.29],0.0001179811780316
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Interstitial lung disease,21958,61,1.70 [1.21-2.41],0.0025528451280475
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23309,61,1.66 [1.18-2.32],0.0032845337401288
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21951,54,1.72 [1.19-2.50],0.004029025801295
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other diseases of pleura,22048,166,1.35 [1.02-1.78],0.0342808972383934
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",19601,1979,1.13 [1.01-1.26],0.0305646233212891
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Functional dyspepsia,18113,491,1.22 [1.02-1.47],0.033315884708998
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22165,736,1.21 [1.03-1.42],0.0184009781757168
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Cholelithiasis,22043,614,1.26 [1.07-1.49],0.0062944423058456
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22340,259,1.40 [1.13-1.72],0.0019818524060978
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Coeliac disease,22159,78,1.49 [1.08-2.06],0.0148106858921248
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,20838,1378,1.16 [1.02-1.31],0.0232302947002268
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22815,283,1.44 [1.17-1.76],0.0004621378541257
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22710,178,1.50 [1.17-1.92],0.0012587405989729
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16551,3765,1.17 [1.07-1.27],0.0007222324984541
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18051,2167,1.21 [1.09-1.33],0.0002677998724791
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16072,188,1.46 [1.17-1.81],0.0006531284882616
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16325,441,1.36 [1.14-1.61],0.0004784444641767
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23032,180,1.49 [1.19-1.86],0.0004824454130271
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23046,165,1.55 [1.24-1.93],0.0001077488940371
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16922,1038,1.24 [1.08-1.42],0.0022315286012412
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",19238,1038,1.24 [1.08-1.43],0.0019377452584204
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,15958,74,1.80 [1.38-2.35],1.283453059591483e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,16147,263,1.38 [1.11-1.71],0.0035683095245009
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23339,138,1.55 [1.20-2.01],0.0009187331659702
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16284,400,1.27 [1.04-1.56],0.0201603471081949
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,17095,1211,1.15 [1.01-1.31],0.0310023776340167
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),15972,88,1.52 [1.13-2.04],0.0055651405123896
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17503,258,1.43 [1.14-1.79],0.0017247249173681
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22795,207,1.32 [1.02-1.71],0.0330034052337309
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22667,79,1.72 [1.31-2.28],0.0001240004753794
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,20948,881,1.18 [1.02-1.36],0.0286752389280113
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",20766,699,1.18 [1.00-1.38],0.0472040064051566
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20197,130,1.40 [1.06-1.84],0.0172963571032911
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20215,252,1.31 [1.03-1.66],0.028314285210954
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19278,5248,1.17 [1.09-1.27],3.001864157828616e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,21539,148,1.48 [1.14-1.92],0.0034056201784668
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21713,28,2.22 [1.62-3.04],6.32818709616479e-07
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,21445,3934,1.17 [1.08-1.26],0.0001214800705793
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18327,816,1.18 [1.02-1.37],0.0288981946692965
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",23486,225,1.28 [1.01-1.63],0.043251345590293
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17634,123,1.43 [1.08-1.90],0.013037570746391
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18668,1157,1.23 [1.08-1.39],0.0014093231552722
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18267,756,1.22 [1.05-1.42],0.0085742894825426
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",23501,175,1.38 [1.09-1.76],0.0084664048046093
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17782,271,1.28 [1.04-1.59],0.0229794518269368
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,23517,975,0.80 [0.65-0.98],0.0336579529517907
